Search
As we come up on the 1-year mark of COVID-19 restrictions, we editors at Consultant360 would like to reflect on the important content published and produced by our valuable key opinion leaders in all areas of medicine.
A new app allows patients with rheumatic and musculoskeletal diseases to choose which measures of disease activity to track—and the results can help direct personalized treatment.
In this podcast, Vinay Pathak, PhD, discusses the implications of his research presented in the session “Live-Cell Imaging of HIV-1 Nuclear Import, Uncoating, and Proviruses” at the Conference on Retroviruses and Opportunistic Infections 2021.
A new study tested the effect of aspirin use on the risk of recurring venous blood clots, compared to long-term oral anticoagulants.
A research letter assessed the extent to which youths are exposed to harmful substances contained in aerosols emitted by electronic cigarettes.
A new study examined the impact of dietary fats on patients with prediabetes and type 2 diabetes.
Gal Bitan, PhD, from UCLA, answers our questions about his research on a potential blood test for diagnosing PD, which can also distinguish between PD and multiple system atrophy.
Despite a lack of clear therapeutic indication, many patients receiving anticoagulation therapy with warfarin are also treated with aspirin. In a recent study, researchers sought to evaluate the frequency and outcomes of this dual therapy.
By Lorraine L. Janeczko
<p>Head Start preschoolers in Michigan who were underweight or overweight at the start of the program entered kindergarten at a healthier weight than similar kids in the community.</p>
<p><span>Lower physical activity was associated with a higher disease burden in children with multiple sclerosis, a new study shows.</span></p>
History shows that most of humankind has been cared for by ordinary, local clinicians who are not in the spotlight.
While previous research has shown that insomnia could be associated with diabetes incidence, the relationship is not well defined. In a recent study, researchers assessed how exposure to insomnia symptoms affected the risk of developing type 2 diabetes.
Keynote speaker Charles L. Raison, MD, shared his expertise on immune-mediated inflammatory disease and the microbial world with the health care professionals from across the autoimmune disease spectrum who gathered at the 4th annual Interdisciplinary Autoimmune Summit (IAS).
The FDA has announced the approval of a new antifungal drug to treat adults with invasive aspergillosis and invasive mucormycosis.
New research finds little evidence to support using noninvasive brain stimulation techniques to prevent and treat episodic and chronic migraines.
In a new review of nearly 31,000 patients from New York, researchers investigated the link between flu and stroke, and whether that link was influenced by race, sex, or urbanicity.
In a new study, researchers assessed the incidence of autoimmune disorders among more than 200 patients who had received treatment for celiac disease.